These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6888459)

  • 1. Intensity of oral anticoagulation, continued.
    N Engl J Med; 1983 Sep; 309(13):794-5. PubMed ID: 6888459
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the control of oral anticoagulation.
    Loeliger EA
    Thromb Diath Haemorrh; 1972 Aug; 28(1):109-19. PubMed ID: 5074987
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral anticoagulant drugs.
    Ansell JE
    N Engl J Med; 1992 Jan; 326(1):68; author reply 68-9. PubMed ID: 1727070
    [No Abstract]   [Full Text] [Related]  

  • 5. [Home use of an ambulatory monitor for the determination of prothrombin time (coaguchek) in patients treated with oral anticoagulants. Multicenter prospective study].
    Cosmi B; Palareti G; Moia M; Pengo V; Testa S
    Minerva Cardioangiol; 1999 Dec; 47(12):598-9. PubMed ID: 10670221
    [No Abstract]   [Full Text] [Related]  

  • 6. Intensity of oral anticoagulation in patients monitored with various thromboplastins.
    N Engl J Med; 1983 May; 308(20):1228-9. PubMed ID: 6843603
    [No Abstract]   [Full Text] [Related]  

  • 7. International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Thromb Haemost; 1985 Feb; 53(1):155-6. PubMed ID: 3992515
    [No Abstract]   [Full Text] [Related]  

  • 8. The prothrombin time and monitoring oral anticoagulant therapy.
    Brownell A; Mackie IJ; Machin SJ
    Br J Hosp Med; 1986 Dec; 36(6):442-3. PubMed ID: 3801752
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory monitoring of oral anticoagulant therapy.
    Ginsberg JS; Hirsh J
    Hematol Pathol; 1989; 3(4):147-51. PubMed ID: 2697715
    [No Abstract]   [Full Text] [Related]  

  • 10. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
    Bailleul E; Van Vaerenbergh K; Lust A
    Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulant monitoring of volunteers using prothrombin activity tests with abnormal control plasmas: a cooperative study.
    Lorberbaum H
    Am J Clin Pathol; 1971 Oct; 56(4):487-92. PubMed ID: 5113402
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
    Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False incoagulable PT-INR results in oral anticoagulant therapy.
    Redaelli R; Corno AR; Somaini MG; Gechtman C; Caimi TM; Baudo F; Morra E
    Thromb Res; 2008; 122(1):137-9. PubMed ID: 17996923
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of prothrombin fragment F1+2 to monitor the effect of oral anticoagulation.
    Bruhn HD; Zurborn KH
    J Heart Valve Dis; 1995 Mar; 4(2):138-40. PubMed ID: 8556173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems of the laboratory control of oral anticoagulant treatment.
    Hummel L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):529-31. PubMed ID: 2465967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral anticoagulation].
    Stenzinger W
    Dtsch Med Wochenschr; 1993 Feb; 118(5):162-3. PubMed ID: 8432237
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of oral anticoagulant therapy.
    Biemer JJ
    Ann Clin Lab Sci; 1988; 18(6):421-8. PubMed ID: 3239946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-monitoring versus standard monitoring of oral anticoagulation.
    Ferretti G; Giannarelli D; Carlini P; Felici A; Ciccarese M; Mandalà M; Cognetti F
    Thromb Res; 2007; 119(3):389-90. PubMed ID: 17023029
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of oral anticoagulant treatment.
    Br Med J; 1971 Nov; 4(5783):317-8. PubMed ID: 5124406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.